Integrated Biopharma Inc SEC filings INBP

Integrated Biopharma Inc has 557 filings in SEC EDGAR's recent list, going back to Nov 21, 1996. Its latest annual report, Form 10-K, was filed on Sep 25, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 8, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 25, 2026 (results of operations). The company's fiscal year ends on June 30.

Form Description Filed Period
DEF 14A Proxy statement Oct 28, 2026 Oct 28, 2026
8-K Current report
Results of operations
 Sep 25, 2026 Sep 25, 2026
10-K Annual report Sep 25, 2026 Jun 30, 2026
8-K Current report
Other events
 Aug 20, 2026 Aug 20, 2026
8-K Current report
Material agreement, Agreement ended
 Jul 2, 2026 Jun 30, 2026
8-K Current report
Results of operations
 May 8, 2026 May 8, 2026
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Other events
 Apr 15, 2026 Apr 14, 2026
8-K Current report
Material agreement
 Feb 18, 2026 Feb 17, 2026
8-K Current report
Results of operations
 Feb 11, 2026 Feb 11, 2026
10-Q Quarterly report Feb 11, 2026 Dec 31, 2025
8-K Current report
Shareholder vote results
 Dec 1, 2025 Dec 1, 2025
8-K Current report
Results of operations
 Nov 10, 2025 Nov 10, 2025
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
DEF 14A Proxy statement Oct 28, 2025 Oct 28, 2025
8-K Current report
Results of operations
 Sep 23, 2025 Sep 23, 2025
10-K Annual report Sep 23, 2025 Jun 30, 2025
8-K Current report
Results of operations
 May 14, 2025 May 14, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Auditor change
 Apr 24, 2025 Apr 24, 2025
8-K Current report
Material agreement, Agreement ended, New debt
 Apr 21, 2025 Apr 15, 2025
8-K Current report
Results of operations
 Feb 13, 2025 Feb 13, 2025
10-Q Quarterly report Feb 13, 2025 Dec 31, 2024
8-K Current report
Shareholder vote results
 Dec 2, 2024 Dec 2, 2024
8-K Current report
Results of operations
 Nov 14, 2024 Nov 13, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
DEF 14A Proxy statement Oct 28, 2024 Oct 28, 2024
8-K Current report
Results of operations
 Sep 23, 2024 Sep 20, 2024
10-K Annual report Sep 20, 2024 Jun 30, 2024
8-K Current report
Results of operations
 May 10, 2024 May 10, 2024
10-Q Quarterly report May 10, 2024 Mar 31, 2024
8-K Current report
Results of operations
 Feb 12, 2024 Feb 12, 2024
10-Q Quarterly report Feb 12, 2024 Dec 31, 2023
8-K Current report
Shareholder vote results
 Nov 27, 2023 Nov 27, 2023
8-K Current report
Results of operations
 Nov 9, 2023 Nov 9, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
DEF 14A Proxy statement Oct 27, 2023 Oct 27, 2023
8-K Current report
Results of operations
 Sep 15, 2023 Sep 15, 2023
10-K Annual report Sep 15, 2023 Jun 30, 2023
8-K Current report
Results of operations
 May 11, 2023 May 11, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Other events
 Mar 21, 2023 Mar 20, 2023
8-K Current report
Material agreement
 Mar 17, 2023 Mar 16, 2023
8-K Current report
Results of operations
 Feb 10, 2023 Feb 10, 2023
10-Q Quarterly report Feb 10, 2023 Dec 31, 2022
8-K Current report
Material agreement
 Dec 6, 2022 Dec 1, 2022
8-K Current report
Shareholder vote results
 Nov 28, 2022 Nov 28, 2022
8-K/A Amended current report
Results of operations
 Nov 14, 2022 Nov 10, 2022
8-K Current report
Results of operations
 Nov 14, 2022 Nov 10, 2022
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
DEF 14A Proxy statement Oct 27, 2022 Nov 28, 2022
8-K Current report
Auditor change
 Oct 24, 2022 Oct 21, 2022
8-K Current report
Results of operations
 Sep 14, 2022 Sep 13, 2022
10-K Annual report Sep 13, 2022 Jun 30, 2022
8-K Current report
Material agreement, Agreement ended
 Jul 15, 2022 Jul 15, 2022
8-K Current report
Officer or director change
 Jun 21, 2022 Jun 20, 2022
8-K Current report
Results of operations
 May 12, 2022 May 11, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Results of operations
 Feb 10, 2022 Feb 10, 2022
10-Q Quarterly report Feb 10, 2022 Dec 31, 2021
8-K Current report
Shareholder vote results
 Nov 29, 2021 Nov 29, 2021
8-K Current report
Results of operations
 Nov 10, 2021 Nov 10, 2021
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
DEF 14A Proxy statement Oct 27, 2021 Oct 27, 2021
8-K Current report
Results of operations
 Sep 2, 2021 Sep 2, 2021
10-K Annual report Sep 2, 2021 Jun 30, 2021
8-K Current report
Agreement ended
 Jul 7, 2021 Jun 30, 2021
8-K Current report
Results of operations
 May 13, 2021 May 13, 2021
10-Q Quarterly report May 13, 2021 Mar 31, 2021
8-K Current report
Other events
 Apr 8, 2021 Apr 8, 2021
8-K Current report
Results of operations
 Feb 12, 2021 Feb 12, 2021
10-Q Quarterly report Feb 12, 2021 Dec 31, 2020
8-K Current report
Other events
 Jan 22, 2021 Jan 22, 2021
8-K Current report
Shareholder vote results
 Nov 30, 2020 Nov 30, 2020
8-K Current report
Results of operations
 Nov 12, 2020 Nov 12, 2020
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
8-K Current report
Officer or director change
 Nov 9, 2020 Nov 4, 2020
DEF 14A Proxy statement Oct 28, 2020 Oct 28, 2020
8-K Current report Sep 24, 2020 Sep 23, 2020
10-K Annual report Sep 23, 2020 Jun 30, 2020
8-K Current report
Results of operations
 May 14, 2020 May 13, 2020
10-Q Quarterly report May 13, 2020 Mar 31, 2020
8-K Current report
Results of operations
 Feb 12, 2020 Feb 12, 2020
10-Q Quarterly report Feb 12, 2020 Dec 31, 2019
8-K Current report
Shareholder vote results
 Dec 3, 2019 Dec 2, 2019
8-K Current report
Results of operations
 Nov 13, 2019 Nov 13, 2019
10-Q Quarterly report Nov 13, 2019 Sep 30, 2019
DEF 14A Proxy statement Oct 28, 2019 Oct 28, 2019
8-K Current report
New debt
 Sep 16, 2019 Sep 16, 2019
10-K Annual report Aug 29, 2019 Jun 30, 2019
8-K Current report
Officer or director change
 May 29, 2019 May 22, 2019
8-K Current report
Results of operations
 May 15, 2019 May 15, 2019
10-Q Quarterly report May 15, 2019 Mar 31, 2019
8-K Current report
Officer or director change
 May 6, 2019 May 1, 2019
10-Q Quarterly report Feb 13, 2019 Dec 31, 2018
S-8 Employee stock plan registration Dec 28, 2018 —
8-K Current report
Shareholder vote results
 Nov 26, 2018 Nov 26, 2018
10-Q Quarterly report Nov 9, 2018 Sep 30, 2018
DEF 14A Proxy statement Oct 29, 2018 Nov 26, 2018
10-K Annual report Sep 12, 2018 Jun 30, 2018
8-K Current report
Agreement ended, Unregistered share sale
 Aug 1, 2018 Jul 31, 2018
10-Q Quarterly report May 9, 2018 Mar 31, 2018
10-Q Quarterly report Feb 9, 2018 Dec 31, 2017
8-K Current report
Shareholder vote results
 Nov 28, 2017 Nov 27, 2017
10-Q Quarterly report Nov 9, 2017 Sep 30, 2017
DEF 14A Proxy statement Oct 27, 2017 Nov 27, 2017
10-K Annual report Sep 1, 2017 Jun 30, 2017
10-Q Quarterly report May 10, 2017 Mar 31, 2017
10-Q Quarterly report Feb 10, 2017 Dec 31, 2016
8-K Current report
Shareholder vote results
 Nov 28, 2016 Nov 28, 2016
8-K Current report
Officer or director change
 Nov 23, 2016 Oct 21, 2016
10-Q Quarterly report Nov 10, 2016 Sep 30, 2016
DEF 14A Proxy statement Oct 28, 2016 Nov 28, 2016
10-K Annual report Sep 2, 2016 Jun 30, 2016
10-Q Quarterly report May 13, 2016 Mar 31, 2016
10-Q Quarterly report Feb 19, 2016 Dec 31, 2015
NT 10-Q Filing Feb 16, 2016 Feb 16, 2016
8-K Current report
Shareholder vote results
 Nov 30, 2015 Nov 30, 2015
10-Q Quarterly report Nov 5, 2015 Nov 5, 2015
DEF 14A Proxy statement Oct 26, 2015 Oct 26, 2015
10-K Annual report Sep 4, 2015 Jun 30, 2015
8-K Current report
Officer or director change
 Jun 5, 2015 Jun 5, 2015
10-Q Quarterly report May 14, 2015 Mar 31, 2015
10-Q Quarterly report Feb 17, 2015 Dec 31, 2014
8-K Current report
Shareholder vote results
 Dec 1, 2014 Dec 1, 2014
10-Q Quarterly report Nov 7, 2014 Sep 30, 2014
DEF 14A Proxy statement Oct 28, 2014 Oct 28, 2014
10-K Annual report Sep 8, 2014 Jun 30, 2014
10-Q Quarterly report May 14, 2014 Mar 31, 2014
10-Q/A Amended quarterly report Feb 13, 2014 Feb 12, 2014
10-Q Quarterly report Feb 12, 2014 Dec 31, 2013
8-K Current report
Shareholder vote results
 Dec 2, 2013 Dec 2, 2013
10-Q Quarterly report Nov 14, 2013 Sep 30, 2013
DEFA14A Additional proxy material Nov 6, 2013 —
DEF 14A Proxy statement Oct 28, 2013 Oct 28, 2013
10-K Annual report Sep 30, 2013 Jun 30, 2013
10-Q Quarterly report May 15, 2013 Mar 31, 2013
10-Q Quarterly report Feb 19, 2013 Dec 31, 2012
NT 10-Q Filing Feb 14, 2013 Feb 14, 2013
8-K Current report
Shareholder vote results
 Nov 27, 2012 Nov 26, 2012
10-Q Quarterly report Nov 19, 2012 Sep 30, 2012
NT 10-Q Filing Nov 14, 2012 Nov 12, 2012
DEFA14A Additional proxy material Nov 5, 2012 —
DEF 14A Proxy statement Oct 29, 2012 Oct 28, 2012
10-K Annual report Oct 15, 2012 Jun 30, 2012
NT 10-K Filing Sep 28, 2012 Sep 28, 2012
D Filing Jul 11, 2012 —
8-K Current report
Material agreement, Agreement ended, New debt
 Jun 29, 2012 Jun 27, 2012
10-Q Quarterly report May 21, 2012 May 21, 2012
NT 10-Q Filing May 16, 2012 May 15, 2012
10-Q Quarterly report Feb 21, 2012 Dec 31, 2011
NT 10-Q Filing Feb 14, 2012 Feb 14, 2012
8-K Current report
Material agreement
 Feb 3, 2012 Feb 3, 2012
8-K Current report
Material agreement
 Jan 26, 2012 Jan 20, 2012
8-K Current report
Material agreement
 Jan 12, 2012 Jan 9, 2012
8-K Current report
Material agreement
 Jan 5, 2012 Dec 29, 2011
8-K Current report
Shareholder vote results
 Nov 28, 2011 Nov 28, 2011
10-Q Quarterly report Nov 21, 2011 Sep 30, 2011
NT 10-Q Filing Nov 14, 2011 Nov 14, 2011
DEF 14A Proxy statement Oct 28, 2011 Oct 28, 2011
10-K Annual report Oct 13, 2011 Jun 30, 2011
8-K Current report
Material agreement
 Oct 11, 2011 Oct 11, 2011
NT 10-K Filing Sep 28, 2011 Sep 28, 2011
10-Q Quarterly report May 17, 2011 Mar 31, 2011
NT 10-Q Filing May 16, 2011 May 16, 2011
10-Q Quarterly report Feb 14, 2011 Dec 31, 2010
8-K Current report
Shareholder vote results, Other events
 Nov 30, 2010 Nov 30, 2010
10-Q Quarterly report Nov 15, 2010 Sep 30, 2010
DEF 14A Proxy statement Oct 28, 2010 Oct 28, 2010
10-K/A Amended annual report Sep 29, 2010 Jun 30, 2010
10-K Annual report Sep 28, 2010 Jun 30, 2010
10-Q/A Amended quarterly report May 19, 2010 May 19, 2010
10-Q Quarterly report May 19, 2010 Mar 31, 2010
NT 10-Q Filing May 17, 2010 May 17, 2010
10-Q Quarterly report Feb 12, 2010 Dec 31, 2009
ARS Annual report to shareholders Nov 25, 2009 Jun 30, 2009
10-Q Quarterly report Nov 19, 2009 Nov 19, 2009
NT 10-Q Filing Nov 16, 2009 Nov 16, 2009
DEFR14A Filing Nov 2, 2009 —
8-K Current report
Auditor change
 Nov 2, 2009 Oct 30, 2009
DEF 14A Proxy statement Oct 28, 2009 Oct 28, 2009
10-K Annual report Oct 13, 2009 Jun 30, 2009
NT 10-K Filing Sep 28, 2009 Jun 30, 2009
10-Q/A Amended quarterly report May 21, 2009 Mar 31, 2009
10-Q Quarterly report May 20, 2009 Mar 31, 2009
NT 10-Q Filing May 15, 2009 Mar 31, 2009
25 Filing Apr 13, 2009 —
8-K Current report
Listing notice
 Apr 13, 2009 Jan 23, 2009
8-K Current report
Officer or director change
 Apr 8, 2009 Apr 8, 2009
8-K Current report
Officer or director change
 Mar 26, 2009 Mar 20, 2009
8-K Current report
Material agreement, Acquisition or sale of assets, Exit or restructuring costs
 Mar 24, 2009 Mar 17, 2009
8-K Current report
Officer or director change
 Mar 2, 2009 Mar 2, 2009
10-Q Quarterly report Feb 20, 2009 Dec 31, 2008
NT 10-Q Filing Feb 17, 2009 Dec 31, 2008
8-K Current report
Officer or director change
 Dec 23, 2008 Dec 22, 2008
8-K Current report
Officer or director change
 Dec 2, 2008 Nov 26, 2008
10-Q Quarterly report Nov 14, 2008 Sep 30, 2008
8-K Current report
Officer or director change
 Nov 10, 2008 Nov 5, 2008
DEFR14A Filing Nov 5, 2008 —
DEF 14A Proxy statement Oct 28, 2008 Oct 28, 2008

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
INBP (OTC)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Hillside, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1016504
Former names
INTEGRATED HEALTH TECHNOLOGIES INC (until Apr 16, 2003); CHEM INTERNATIONAL INC (until May 14, 2002)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.